INDEX 450 Congenital malformations, neonatal transport and, 362, 370t Continuous infusion, UVC, 127 Continuous positive airway pressure (CPAP), 12 misplaced mask, 53 pneumothorax and, 70–71 CPAP. See Continuous positive airway pressure (CPAP) C-reactive protein (CRP), 296 Cyanosis, 9–10, 51, 58, 63 prematurity without, 10 Cyanotic congenital heart disease, 10 Cytomegalovirus (CMV), 301 D Decreased breath sounds, 58 Dextrose delivery, 193–194 Diabetes mellitus, babies of women with, 56 Diaphragmatic hernia, 53 Diarrhea, 192 Difficult births and respiratory distress, 56 Discharge planning for neonatal abstinence syndrome (NAS) and neonatal opioid withdrawal syndrome (NOWS), 397–399 Disconnected catheter, 128 E Early term babies, breastfeeding of, 219–220 Eat, Sleep, Console (ESC) method, 390–391, 395 Electrolytes, 344–345 Embolus, 35, 129 Erb-Duchenne paralysis, 55 Erythromycin, 298 ESC. See Eat, Sleep, Console (ESC) method Excess fluid, umbilical catheter, 128 Excessive handling, 54 Excessive urine output, 192 Exchange transfusion, 265, 269–271 Extremely preterm babies fluid needs in, 194 need for transport to regional perinatal center, 362 Eye damage and oxygen, 15–16 F Family-centered care, 393 Feeding, 213–252 algorithm for physical assessment, 236f of appropriate for gestational age babies, 223–226 assessment of, 236f, 341t babies at risk for developing problems with, 221t–223t Eat, Sleep, Console (ESC) method, 390–391, 395 frequency of, 224–225 goals of, 218 importance of breastfeeding, 218–221 increasing volume of, 226 iron supplementation and, 230–231 jaundice and, 262–263 nasogastric tube, 233, 243–252 neonatal abstinence syndrome (NAS) and neonatal opioid withdrawal syndrome (NOWS) and, 390–393 posttest, 242 preterm babies, 226t, 238 pretest, 215–216 principles, 217–231 recommended routines, 239–240 risks of oral and/or gastric tube, 221 satisfactory growth and, 227–230 self-test, 227, 231, 234, 241 sick and at-risk babies, 334, 341 of small for gestational age babies, 226–227 target volume per, 226 total daily volume of milk needed, 223–224 tube, 232–238 vitamin supplementation and, 230 Fenton preterm growth charts, 228f–229f Finnegan Neonatal Abstinence Scale–Short Form, 390 Finnegan Neonatal Abstinence Scoring System (FNASS), 390 Flaring, 338 Fluctuations, oxygen concentration, 12–13 Fluid loss, 192 FNASS. See Finnegan Neonatal Abstinence Scoring System (FNASS) Fourth intercostal space, locating, 99f G Gasping, 338 Gentamicin, 296–298 Gestational age assessment, 334 prior to neonatal transport, 363 Gonococcal infections, 299 Group B b-hemolytic streptococcus, 56 Growth charts, 227–230 Grunting, 51, 58, 338 H Handwashing while caring for sick and at-risk babies, 335 HBV. See Hepatitis B virus (HBV) Health Insurance Portability and Accountability Act (HIPAA), 363 Health professionals, infection control for, 317–318 Heart rate monitoring, 64 reference range, 336 Heated and humidified oxygen and air, 11, 29–32 Hematocrit value, 345–346 low, 64 very high, 60 Hematoma, 35 Hemoglobin, 6 Hemolytic disease, 258, 259 Hemorrhagic shock, 129 Heparin lock, 126–127 Hepatitis B vaccine, 305t Hepatitis B virus (HBV), 302–305 Herpes simplex virus (HSV), 306–307 HIPAA. See Health Insurance Portability and Accountability Act (HIPAA) HIV, 307–309 Hospital-acquired infections, 288, 294, 315 HSV. See Herpes simplex virus (HSV) Human (breast) milk, 218–221 Hyperbilirubinemia, 253–282 bilirubin measurement and detection and, 257–258 14-Index_BKIII_PCEP_449-456.indd 450 6/2/21 12:14 PM
Previous Page Next Page